Ashe Gena L's Form 4 filing
Anterix Inc.ATEX · filed Jun 1, 2022
- Accession no.
- 0001209191-22-033334
- Filed
- Jun 1, 2022
- Trade date
- May 27-Jun 1, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $243.5K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ashe Gena LCIK 0001669943 | Officer (Chief Legal Officer & Corp Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2022 | Common Stock | FTax withholdingDisposed | −2,819 | $42.47 | −$119,722.93 | 39,992 | Direct | |
| Jun 1, 2022 | Common Stock | SSaleDisposed | −5,680 | $42.87F2 | −$243,501.6 | 34,312 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.69 to $43.14. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.